An IDH1/2 mutant diffusely infiltrating astrocytoma has also had a loss of nuclear alpha-thalassemia/mental retardation syndrome X-linked expression (ATRX) status and TP53 mutations [1, 3]. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).